A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Published findings reveal financial, emotional and logistical reasons behind missed dental visits, more tooth decay.

For a while, Danish drugmaker Novo Nordisk A/S looked unstoppable. It was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat ...

The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...

When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...

Robert F. Kennedy Jr., the secretary of Health and Human Services, is eyeing an overhaul of two more key entities as part of his ongoing effort to reshape health policy. And President Donald Trump ...

Discover the rise of "Ozempic face" linked to weight loss drugs like semaglutide, its cosmetic effects, and treatments like ...

Whether you’re talking to a partner, a friend, or your doctor, weight loss can be a sensitive topic. And if you’re thinking ...

U.S. drugmaker Madrigal Pharmaceuticals has struck a licensing deal with CSPC Pharmaceutical Group that could be worth more than $2 billion for the Chinese company if it results in a new drug for a ...

ASX companies such as LTR Pharma are finding smarter ways to stretch the value of existing assets and launch into broader ...

A growing number of people are turning to medications like Ozempic, Wegovy, and Mounjaro to aid in weight loss and manage ...

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...